Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human gliomas with wild-type p53 express bcl-2.

Cancer research - 1 Mar 1995

Alderson L M, Castleberg R L, Harsh G R, Louis D N, Henson J W

Abstract excerpt

Human astrocytomas frequently overexpress wild-type p53, which suggests that gliomas have evolved a mechanism to subvert p53-mediated apoptosis. bcl-2 inhibits apoptosis mediated by p53, and it is expressed in several human cancers. We therefore examined a series of human gliomas to determine whether bcl-2 is expressed and whether this expression is associated with tumors which have wild-type p53. Twenty-eight...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Proto-Oncogene Proteins
Share to Apoptosis
Share to Gene Expression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Immunohistochemistry

Share to Mutation

Share to Proto-Oncogene Proteins c-bcl-2

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 7867012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human gliomas with wild-type p53 express bcl-2.PMID 7867012Read ↗

Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations.Semantic proximity Read ↗

Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineageSemantic proximity Read ↗

BCL-2 promotes migration and invasiveness of human glioma cells.Semantic proximity Read ↗

Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.Semantic proximity Read ↗

The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis.Semantic proximity Read ↗

The bcl-2 gene status of human head and neck cancer cell lines.Semantic proximity Read ↗

TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.Semantic proximity Read ↗

Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomasSemantic proximity Read ↗

BCL2 regulates neural differentiation.Semantic proximity Read ↗

Association of TP53 mutation, p53 overexpression, and p53 codon 72 polymorphism with susceptibility to apoptosis in adult patients with diffuse astrocytomas.Semantic proximity Read ↗

Elevated serum Bcl-2 in children with temporal lobe epilepsySemantic proximity Read ↗

Differential p53, p21, mdm2 and Rb regulation in glioma cell lines that overexpress wild-type p53.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.